Scholars Central

Conference abstractPublished 2012

Synergy and mechanism of antioxidants N-Acetylcysteine and Allopurinol in combating diabetic cardiomyopathy and myocardial ischemic injury

Authors: Zhengyuan XIA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Hyperglycemia-induced oxidative stress facilitates the development of diabetic cardiomyopahty (PMID: 22389139) and exacerbates myocardial ischemic reperfusion (MI/R) injury. Antioxidants N-acetylcysteine (NAC) and allopurinol (ALP) can synergistically reduce MI/R injury in streptozotocin (STZ)-induced diabetes (PLoS One. 2011; 6:e23967), but the underlying mechanism is unclear. We postulated that NAC and ALP may attenuate MI/R injury primarily through phosphatidylinositol 3-kinase (PI3K)/Akt and Jak2/STAT3 mediated endothelial nitric oxide synthase (eNOS) activation in diabetes. Control (C) or STZ-induced diabetic (D) rats were untreated or treated with NAC (1.5g/kg/day) or ALP (100 mg/kg/day) or their combination for four weeks starting one week after STZ injection. NAC and ALP synergistically decreased myocardial infarct size in D rats subjected to 30 minutes of coronary artery occlusion and two hours of reperfusion, which was associated with restoration of myocardial phosphorylations of Akt, STAT3 and eNOS. Exposure of cultured rat cardiomyocytes to high glucose and 45 min hypoxia and 2 hours reoxygenation induced post-hypoxic cell death reflected as an increase of lactate dehydrogenase (LDH) leakage and reduced cell viability. NAC and ALP synergistically decreased post-hypoxic cell death that was associated with increased phosphorylations of Akt, STAT3 and eNOS. The PI3K inhibitor wortmannin and Jak2 inhibitor AG490, respectively attenuated NAC and ALP�s protective effects in vivo and in vitro. We conclude that activation of both the PI3K/Akt and the Jak2/ STAT3 signaling are major mechanisms by which NAC and ALP synergistically attenuated MI/R injury in diabetes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Diabetes & Metabolism.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Diabetes & Metabolism
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Zhengyuan XIA”